We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$2.33B
AUM Growth
+$70.8M
Cap. Flow
+$37.5M
Cap. Flow %
1.61%
Top 10 Hldgs %
21.75%
Holding
402
New
31
Increased
179
Reduced
126
Closed
23

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$14M
2
HAL icon
Halliburton
HAL
+$11.6M
3
C icon
Citigroup
C
+$10.4M
4
SCHW
Charles Schwab
SCHW
+$6.69M
5
BIDU icon
Baidu
BIDU
+$5.93M

Top Sells

Rank Stock Value
1
ESV
Ensco Rowan plc
ESV
+$10.1M
2
ILMN icon
Illumina
ILMN
+$9.62M
3
CVX icon
Chevron
CVX
+$7.82M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.01M
5
PM icon
Philip Morris
PM
+$5.96M

Sector Composition

Rank Sector Weight
1 Energy 13.45%
2 Financials 12.82%
3 Technology 12.05%
4 Consumer Discretionary 11.98%
5 Healthcare 11.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAS
401
DELISTED
AGL Resources Inc
GAS
-4,446
Closed -$210K
ARMH
402
DELISTED
ARM HOLDINGS PLC ADS
ARMH
-9,940
Closed -$544K

Similar funds

Cullen/Frost Bankers's Q1 2014 Portfolio in Review

As of Q1 2014, Cullen/Frost Bankers held 402 positions worth $2.33B, up 3.1% from $2.25B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Cullen/Frost Bankers's Q1 2014 filing shows 31 new, 179 increased, 126 reduced and 23 closed positions. Its largest new stake was Citigroup: 209,084 shares worth $9.95M. The largest sale was Ensco Rowan plc, an estimated $10.1M.

By sector, the portfolio is most concentrated in Energy at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Cullen/Frost Bankers's largest Q1 2014 buy was Citigroup: 209,084 shares worth $9.95M.
  • Cullen/Frost Bankers added most to Boeing in Q1 2014, an estimated $14M increase.
  • Cullen/Frost Bankers's biggest Q1 2014 reduction was Ensco Rowan plc, cutting an estimated $10.1M.
  • Cullen/Frost Bankers fully exited Vertex Pharmaceuticals in Q1 2014, selling an estimated $6.01M.
  • Cullen/Frost Bankers's ten largest holdings make up 22% of its $2.33B portfolio in Q1 2014.
  • Cullen/Frost Bankers opened 31 new positions and closed 23 in Q1 2014.
  • Cullen/Frost Bankers's portfolio value rose 3.1% quarter-over-quarter to $2.33B.

Based on Cullen/Frost Bankers's 13F filing for Q1 2014, filed 29 Apr 2014.